Technology area: Biotechnology & Pharmaceuticals
4 pending office actions • 4 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready
Cap Diagnostics LLC Dba Pathnostics currently has 4 pending office actions in the Biotechnology & Pharmaceuticals technology area. These 4 actions are distributed across 4 distinct examiners, meaning that every active case is being reviewed by a different person. This 1 to 1 ratio of actions to examiners suggests that the company's prosecution results are diversified across multiple perspectives.
The portfolio is also spread across 4 distinct art units, which matches the number of pending office actions and examiners. This alignment indicates that each of the 4 pending office actions is being handled in a different technical group within the patent office. Such a distribution requires the company to adapt its strategy to the specific requirements of 4 different art units simultaneously.
The busiest examiner for the company is FERNANDEZ, SUSAN EMILY, who is responsible for 1 pending office action. This 1 action is part of the 4 total pending office actions, showing that no single examiner has a concentrated workload for this company. The presence of 4 distinct examiners in 4 distinct art units for 4 actions reflects a highly decentralized prosecution landscape for the company's biotechnology filings.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (25%) |
| §103 only | 1 (25%) |
| Multi-statute (no §101) | 2 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| FERNANDEZ, SUSAN EMILY | 1 | 52.3% | +60.9% |
| OYEYEMI, OLAYINKA A | 1 | 60.4% | +46.5% |
| HAQ, SHAFIQUL | 1 | 64.8% | +55.2% |
| SPANGLER, JOSEPH RANKIN | 1 | 40.8% | +70.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18824184 | METHODS FOR TREATING POLYMICROBIAL INFECTIONS | FERNANDEZ, SUSAN EMILY | — |
| 18807571 | METHODS AND SYSTEMS FOR DETERMINING SUITABILITY OF COMPOSITIONS FOR INHIBITING GROWTH OF POLYMICROBIAL SAMPLES | OYEYEMI, OLAYINKA A | — |
| 18669370 | METHODS AND SYSTEMS FOR DETECTING URINARY TRACT INFECTIONS | HAQ, SHAFIQUL | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17830227 | METHODS AND SYSTEMS FOR PREPARING THERAPEUTIC SOLUTIONS FOR POLYMICROBIAL INFECTIONS | SPANGLER, JOSEPH RANKIN | 14d |
| 18824184 | METHODS FOR TREATING POLYMICROBIAL INFECTIONS | FERNANDEZ, SUSAN EMILY | — |
| 18807571 | METHODS AND SYSTEMS FOR DETERMINING SUITABILITY OF COMPOSITIONS FOR INHIBITING GROWTH OF POLYMICROBIAL SAMPLES | OYEYEMI, OLAYINKA A | — |
| 18669370 | METHODS AND SYSTEMS FOR DETECTING URINARY TRACT INFECTIONS | HAQ, SHAFIQUL | — |
| Art Unit | Apps |
|---|---|
| 1651 | 1 |
| 1681 | 1 |
| 1678 | 1 |
| 1656 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18824184 | METHODS FOR TREATING POLYMICROBIAL INFECTIONS | FERNANDEZ, SUSAN EMILY | 1651 | §102§103 | Non-Final OA | — | Pending | Sep 04, 2024 |
| 18807571 | METHODS AND SYSTEMS FOR DETERMINING SUITABILITY OF COMPOSITIONS FOR INHIBITING GROWTH OF POLYMICROBIAL SAMPLES | OYEYEMI, OLAYINKA A | 1681 | §103§112 | Non-Final OA | — | Pending | Aug 16, 2024 |
| 18669370 | METHODS AND SYSTEMS FOR DETECTING URINARY TRACT INFECTIONS | HAQ, SHAFIQUL | 1678 | §101§103 | Non-Final OA | — | Pending | May 20, 2024 |
| 17830227 | METHODS AND SYSTEMS FOR PREPARING THERAPEUTIC SOLUTIONS FOR POLYMICROBIAL INFECTIONS | SPANGLER, JOSEPH RANKIN | 1656 | §103 | Non-Final OA | 14d | Pending | Jun 01, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialCap Diagnostics LLC Dba Pathnostics has 4 pending office actions as of October 2026, spread across 4 art units and 4 examiners.
Susan Emily Fernandez has the most, with 1 of Cap Diagnostics LLC Dba Pathnostics's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
